Tamara L Wexler, M.D., Ph.D.

faculty photo
Adjunct Associate Professor of Medicine (Endocrinology, Diabetes and Metabolism)
Department: Medicine

Contact information
240 E 38th St 15th Floor
New York, NY 10016
Education:
BA (Chemistry)
Princeton University, 1993.
MD/PhD
University of Pennsylvania School of Medicine, 2003.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Tamara L. Wexler, MD, PhD, is an endocrinologist specializing in neuroendocrinology and reproductive endocrinology, nationally recognized for her expertise in post-TBI pituitary dysfunction. She has served as an Attending Physician in Internal Medicine at the Massachusetts General Hospital and as the founding Director of the NYU Langone Medical Center Pituitary Center.

Dr. Wexler received her MD and her PhD in Neuroscience from the University of Pennsylvania. She completed her Internal Medicine residency and Endocrinology fellowship at the Massachusetts General Hospital, where she was part of the Neuroendocrine Unit, designed and ran national clinical trials on the effects of growth hormone, and served for 12 years on the Optimum Care Committee.


Dr. Wexler is a Clinical Associate Professor at NYU, an Adjunct Assitant Professor at the University of Pennsylvania, and founded Neuroendocrine Associates to provide education and clinical care regarding the neuroendocrine sequelae of brain injury, with a focus on underserved areas.

Description of Other Expertise

While on staff at the MGH, Dr. Wexler spent four years at McKinsey & Company, where she served as the Global Endocrinology Lead. She is an elected member of the Endocrine Society Clinical Guidelines Committee, and of the University of Pennsylvania Institute for Diabetes, Obesity, and Metabolism Leadership Council. She is a speaker and moderator at academic medical centers and national conferences on the topic of pituitary function, reproductive endocrinology, and post-TBI endocrine disorders. Her publications appear in the Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology, among other journals.

Description of Research Expertise

Tamara L. Wexler, MD, PhD, is an endocrinologist specializing in neuroendocrinology and reproductive endocrinology, nationally recognized for her expertise in post-TBI pituitary dysfunction. She has served as an Attending Physician in Internal Medicine at the Massachusetts General Hospital and as the founding Director of the NYU Langone Medical Center Pituitary Center.

Dr. Wexler received her MD and her PhD in Neuroscience from the University of Pennsylvania. She completed her Internal Medicine residency and Endocrinology fellowship at the Massachusetts General Hospital, where she was part of the Neuroendocrine Unit, designed and ran national clinical trials on the effects of growth hormone, and served for 12 years on the Optimum Care Committee.

Dr. Wexler's current research focuses on the neuroendocrine sequelae of traumatic brain injury and Long COVID (Post-Acute Sequelae of SARS CoV-2 infection).

Selected Publications

Wright TJ, Pyles RB, Sheffield-Moore M, Deer RR, Randolph KM, McGovern KA, Danesi CP, Gilkison CR, Ward WW, Vargas JA, Armstrong PA, Lindsay SE, Zaidan MF, Seashore J, Wexler TL, Masel BE, Urban RJ.: Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study. Mol Cell Endocrinol 579(112071), January 2024 Notes: doi: 10.1016/j.mce.2023.112071. Epub 2023 Oct 8. PMID: 37816478.

Wexler TL, Reifschneider K, Backeljauw P, Cárdenas JF, Hoffman AR, Miller BS, Yuen KCJ: Growth Hormone Deficiency Following Traumatic Brain Injury in Pediatric and Adolescent Patients: Presentation, Treatment, and Challenges of Transitioning from Pediatric to Adult Services. J Neurotrauma 49(13-14): 1274-1285, July 2023 Notes: doi: 10.1089/neu.2022.0384. Epub 2023 Mar 21.

Wexler, Tamara L: Neuroendocrine Disruptions Following Head Injury. Current neurology and neuroscience reports 23(5): 213-224, May 2023 Notes: https://doi.org/10.1007/s11910-023-01263-5 Epub 2023 May 6.

Wexler TL, Page-Wilson G: Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies. Br J Clin Pharmacol 89(4): 1304-1317, April 2023 Notes: doi: 10.1111/bcp.15660. Epub 2023 Jan 30.

Tamara Wexler: Live talk on Pituitary World News with Dr. Lewis Blevins. Podcast Pituitary World News 2023 Notes: https://pituitaryworldnews.org/live-talk-session-11-july-14-2022-pituitary-dysfunction-after-traumatic-brain-injuries-tbi/

Tamara Wexler: Chronic hormonal effects to look for following traumatic brain injury. Healio 2023 Notes: https://www.healio.com/news/endocrinology/20230620/video-chronic-hormonal-effects-to-look-for-following-traumatic-brain-injury.

Tamara Wexler: Neuroendocrine Dysfunction after Concussion: What Patients & Families Should Know. Concussion Legacy Foundation virtual lecture 2023 Notes: https://www.youtube.com/watch?v=JdJvHgQdZms.

Elliott, T., Hsiao, Y.-Y., Randolph, K, Urban, R. J., Sheffield-Moore, M., Pyles, R. B, Masel, B. E., Wexler, T., & Wright, T. J. : Efficient assessment of brain fog and fatigue: Development of the fatigue and altered cognition scale (FACs). Brain Injury 37(8): 815-816, 2023.

Yuen, K. C. J., Masel, B., Jaffee, M. S., O'Shanick, G., Wexler, T. L., Reifschneider, K., Urban, R. J., Hoang, S., Kelepouris, N., & Hoffman, A. R. : A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 66(101494), October 2022 Notes: https://doi.org/10.1016/j.ghir.2022.101495.

Wexler TL,Zasler ND, Katz DI, Zafonte RD: Neuroendocrine Dysfunction After Traumatic Brain Injury. Brain Injury Medicine, Third Edition (chapter 54). Demos Medical Publishing, Springer Publishing Company, New York, NY, 2021.

back to top
Last updated: 03/21/2024
The Trustees of the University of Pennsylvania